Loading…
Healthcare Triangle, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in HCTI.
▼ -100.0% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $37.98 | $14,730.84 | $41,010.30 | $26,892.00 | |
| P/S | 0.4x | 0.4x | 0.5x | 0.4x | 0.2x |
| P/B | — | 0.5x | — | — | 1.2x |
| EPS | -$152.30 | -$15,749.34 | -$30,159.72 | -$51,462.37 | |
| Profit margin | -41.16% | -68.22% |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| IRIXIridex Corp | $0.71 | — | — | — | -73.15% | $12.3M |
| QNRXQuoin Pharmaceuticals Ltd. | $6.12 | — | 0.7x | — | -575.73% | $12.29M |
| MBRXMoleculin Biotech, Inc. | $0.65 | 0.0x | 0.4x | — | -1371.64% | $12.66M |
| ASBPAspire Biopharma Holdings, Inc. | $8.51 |
Healthcare Triangle, Inc., a healthcare information technology company, focuses on advancing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations; Blockchain infrastructure; and Cybersecurity navigator. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, the company offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery capabilities on public cloud. It also serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. Healthcare Triangle, Inc. was incorporated in 2019 and is based in Pleasanton, California.
Company description provided by Yahoo Finance.
| -51.03% |
| -26.16% |
| -31.29% |
| ROE | — | -94.94% | — | — | -237.72% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 0.9x |
| — |
| -1032.14% |
| $11.94M |
| PDSBPDS Biotechnology Corp | $0.21 | — | — | — | -543.97% | $11.8M |
| SNTISenti Biosciences Holdings, Inc. | $0.38 | — | 4.6x | — | -466.46% | $11.74M |